<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>GSEA_expr_set_commonEffectOnly_expr_set_commonEffectOnly.Phenotypes_commonEffectOnly.cls<br>#REST_versus_shSCR.Phenotypes_commonEffectOnly.cls<br>#REST_versus_shSCR_repos</td></tr><tr><td>Phenotype</td><td>Phenotypes_commonEffectOnly.cls#REST_versus_shSCR_repos</td></tr><tr><td>Upregulated in class</td><td>shSCR</td></tr><tr><td>GeneSet</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td></tr><tr><td>Enrichment Score (ES)</td><td>-0.3678076</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>-1.5769331</td></tr><tr><td>Nominal p-value</td><td>0.042959426</td></tr><tr><td>FDR q-value</td><td>0.28684837</td></tr><tr><td>FWER p-Value</td><td>0.97</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1' src='enplot_CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1_333.png'><br><br><caption>Fig 1: Enrichment plot: CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='9' border='1'><th class='richTable'></th><th class='richTable'>PROBE</th><th class='richTable'>DESCRIPTION<br>(from dataset)</th><th class='richTable'>GENE SYMBOL</th><th class='richTable'>GENE_TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=CA2'>CA2</a></td><td>na</td><td></td><td></td><td>15</td><td>1.727</td><td>0.0649</td><td>No</td></tr><tr><td class='lessen'>2</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=EVL'>EVL</a></td><td>na</td><td></td><td></td><td>51</td><td>1.427</td><td>0.0602</td><td>No</td></tr><tr><td class='lessen'>3</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=JAK1'>JAK1</a></td><td>na</td><td></td><td></td><td>205</td><td>0.618</td><td>-0.2980</td><td>No</td></tr><tr><td class='lessen'>4</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=GAS5'>GAS5</a></td><td>na</td><td></td><td></td><td>233</td><td>-0.511</td><td>-0.3371</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>5</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=MTHFD1'>MTHFD1</a></td><td>na</td><td></td><td></td><td>242</td><td>-0.597</td><td>-0.3219</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>6</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=TOP1MT'>TOP1MT</a></td><td>na</td><td></td><td></td><td>250</td><td>-0.626</td><td>-0.3024</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>7</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=SNHG7'>SNHG7</a></td><td>na</td><td></td><td></td><td>257</td><td>-0.675</td><td>-0.2774</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>8</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=MYC'>MYC</a></td><td>na</td><td></td><td></td><td>263</td><td>-0.703</td><td>-0.2481</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>9</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=FAM120AOS'>FAM120AOS</a></td><td>na</td><td></td><td></td><td>275</td><td>-0.752</td><td>-0.2314</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>10</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=CAD'>CAD</a></td><td>na</td><td></td><td></td><td>277</td><td>-0.753</td><td>-0.1888</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>11</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=TBC1D5'>TBC1D5</a></td><td>na</td><td></td><td></td><td>285</td><td>-0.792</td><td>-0.1593</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>12</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=SOX12'>SOX12</a></td><td>na</td><td></td><td></td><td>287</td><td>-0.798</td><td>-0.1140</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>13</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=IMPDH2'>IMPDH2</a></td><td>na</td><td></td><td></td><td>299</td><td>-0.909</td><td>-0.0878</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>14</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=YDJC'>YDJC</a></td><td>na</td><td></td><td></td><td>308</td><td>-0.955</td><td>-0.0511</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>15</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=RRP1B'>RRP1B</a></td><td>na</td><td></td><td></td><td>314</td><td>-0.982</td><td>-0.0050</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>16</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=PRR11'>PRR11</a></td><td>na</td><td></td><td></td><td>326</td><td>-1.028</td><td>0.0283</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>17</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=RPL22L1'>RPL22L1</a></td><td>na</td><td></td><td></td><td>363</td><td>-1.388</td><td>0.0187</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>18</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=OSR2'>OSR2</a></td><td>na</td><td></td><td></td><td>367</td><td>-1.410</td><td>0.0956</td><td bgcolor='#CCFFCC'>Yes</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1.xls'>[plain text format]</a></caption></table></div><br><div class='image'><img name='CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1' src='CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1_334.png'><br><br><caption>Fig 2: CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 &nbsp&nbsp <br> Blue-Pink O' Gram in the Space of the Analyzed GeneSet</caption></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_335.png'><br><br><caption>Fig 3: CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</b></caption></div><br></body></html>